Consolidated Financial Statements Summary

(All financial information has been prepared in accordance with accounting principles generally accepted in Japan) November 1, 2011

Company name : TEIJIN LIMITED (Stock code 3401)

Contact person : Masahiro Ikeda General Manager of IR Office TEL: +81-(0)3-3506-4395

(Amounts less than one million yen are omitted)

1. Highlight of the Second quarter of FY2011 (April 1, 2011 through September 30, 2011)(1) Consolidated financial results （Percentages are year-on-year changes）

% % % %

(1.6) 0.7 5.7 (20.4)

11.0 636.8 ― ―

cf. Comprehensive income : 9,903million yen (FY2010: 2,225million yen)

※1 E.P.S.: Earnings per share

(2) Consolidated financial position

cf. Shareholders' equity : 290,074million yen(FY2010: 284,236million yen)

2. Dividends

Note: Revision of outlook for dividends in the second quarter: No

3. Forecast for operating results in the year ending March 31, 2012 (Fiscal 2011)

（Percentages are year-on-year changes）

% % % %

9.1 3.0 (0.7) (4.7) 24.38

Note: Revision of outlook for fiscal 2011 consolidated operating results in the second quarter: Yes

Operating income

Million yen Million yen

-

- 2.00

- 3.00

FY2011

Ordinary income Net income

Million yen Million yen

Net sales

50,000 24,000

Dividends per share

1Q 2Q 3Q 4Q Annual

E.P.S.Yen

Period

Yen

890,000 50,000

YenFY2010

FY2011

FY2011 (Outlook)

-

Yen

English translation from the original Japanese-language document

http://www.teijin.co.jp/english/index.html

21,663

20,492

9,184

11,546

393,567

For the second quarter ended September 30, 2011

For the second quarter ended September 30, 2010

As of Setember 30, 2011As of March 31, 2011

(For the year ended September 30, 2011)

E.P.S.※1

Yen

Diluted E.P.S.

Yen

Million yen

For the second quarter ended September 30, 2011

For the second quarter ended September 30, 2010

20,652

784,520

Million yen

761,534 307,698

37.0

9.33

11.74

20,511

Million yen

11.72

Total assets

9.32

399,869

Million yen

Net incomeNet sales Operating income Ordinary income

Million yenMillion yen

Net assetsShareholders' equity

ratio

310,347

%

37.3

3.00 6.00

3.00

Yen Yen

5.00

Appropriate Use of Forecasts and Other Information and Other Matters

All forecasts in this document are based on management’s assumptions in light of information currently available and involve

certain risks and uncertainties. Actual results to differ materially from these forecasts. For information on these forecasts, refer to

"Qualitative Information on Outlook for Operating Results", beginning on page 6.

1. Qualitative Information and Financial Statements

Qualitative Information on Results of Operations

Analysis of Consolidated Results of Operations

Sales and Income

Despite the significant damage to Japan’s economy in the first half of fiscal 2011—the fiscal year ending March 31,

2012—caused by the Great East Japan Earthquake of March 11, 2011, the positive impact of reconstruction efforts

was felt from the summer forward. However, the domestic environment continued to reflect a compound crisis that

included long-standing economic stagnation and fiscal deterioration, as well as a record-high yen. Global economic

conditions remained harsh, owing to a variety of factors, including concern regarding European sovereign risks;

sluggish consumer spending in the United States, attributable to lagging employment recovery; and slowing

economic growth in the People’s Republic of China (PRC)—until recently the principal driving force behind the

global economy—as a consequence of monetary restraint.

In this environment, Teijin reported first-half consolidated net sales of ¥393.6 billion, down 1.6% from the first half

of fiscal 2010. Operating income edged up 0.7%, to ¥20.7 billion. Ordinary income rose 5.7%, to ¥21.7 billion,

while net income fell 20.4%, to ¥9.2 billion.

Although the impact of the earthquake, together with stagnating demand for use in liquid crystal display (LCD)

televisions, computers and other electronics equipment, pushed down sales and operating income in the Films and

Plastics segment, overall net sales and operating income remained essentially level with the fiscal 2010 first half,

as a firm sales volume supported increased sales and operating income in a number of segments, including

High-Performance Fibers and Polyester Fibers. The increase in ordinary income reflected better results at

unconsolidated affiliates accounted for by the equity method. The drop in net income was attributable to a decline

in extraordinary income and an increase in income taxes resulting from an adjustment of deferred income taxes.

Business Segment Results

High-Performance Fibers

Sales in the High-Performance Fibers segment amounted to ¥54.4 billion. Operating income was ¥4.2 billion.

Aramid Fibers

Results were firm and key products remained in full production.

The market for Twaron® para-aramid fibers was solid, particularly for use in automotive-related materials,

ballistic-protection products and fiber optic cables. Although the Great East Japan Earthquake hindered domestic

demand from some quarters for use in composite materials and civil engineering applications, flourishing demand

overseas for automotive-related applications continued to support robust overall demand for Technora®

para-aramid fibers. While indications of forthcoming production adjustments hampered demand for Teijinconex®

meta-aramid fibers in Japan for use in certain types of filters and in Europe for use in industrial materials, demand

- 1 -

was firm for key applications, notably protective clothing. As a consequence, all three products remained in full

production. In this environment, we continued to push ahead with active efforts to cultivate new applications with

the aim of further growing this business.

Carbon Fibers and Composites

Demand remained brisk for use in aircraft.

Demand for Tenax® carbon fibers remained brisk for use in aircraft. Among general industrial applications, demand

was solid for use in the wind power and other natural energy industries, as well in civil engineering and

infrastructure repair, while demand for use in pressure vessels was hampered by the economic downturn in

Europe. In Asia, sales for use in compounds and in sports and leisure equipment were sluggish.

In this environment, we continued to restore sales prices, and at the same time cultivated markets in the PRC and

other emerging economies. Having started production on our new thermoplastic prepreg facilities in Germany,

primarily for use in aircraft, we began sample shipments.

Having succeeded in developing mass-production technologies for carbon fiber–reinforced plastic (CFRP) made

with thermoplastic resin that reduce the time required for the molding of parts to less than one minute, we actively

marketed this new material for a variety of applications, particularly to the automotive industry. In addition to

winning the Global Automotive Carbon Composites Technology Innovation Award from world-renowned market

research firm Frost & Sullivan for 2011, these technologies were honored with the Overall Innovation Award, as

well as winning the Best Product Innovation category, at the 2011 ICIS Innovation Awards, an event run by

International Chemical Information Service (ICIS), a leading United Kingdom–based provider of information for the

chemicals industry.

Polyester Fibers

The Polyester Fibers segment, which also includes the polyester raw materials and polymerization businesses,

generated sales of ¥53.9 billion and operating income of ¥2.0 billion. Demand rallied, particularly for automotive

applications.

Demand, particularly for automotive applications—including seat belts, vehicle seats, fabrics for tires and tire

cords—flagged in the immediate aftermath of the Great East Japan Earthquake, but began to rise in the summer,

shored up by a sharp recovery in automobile production. This contributed to robust sales, as did successful efforts

to capitalize on domestic demand associated with official energy saving initiatives and measures to promote cooler

business attire, as well as on demand for materials for civil engineering and construction applications related to

post-quake reconstruction. The segment’s profit structure continued to improve steadily, thanks in large part to cost

reductions achieved by shifting production of filament yarn overseas.

In the first half of fiscal 2011, proactive steps taken by subsidiary Teijin Fibers Limited to reduce its impact on the

environment were honored with a Good Practice Award in the 13th Green Purchasing Awards, sponsored by

Japan’s Green Purchasing Network. In particular, recognition was given to the company’s extensive record of

achievement, which includes ECO CIRCLE™, a closed-loop recycling system that has facilitated, among others,

partnerships and collaborative product development with companies in other industries.

- 2 -

Films and Plastics

Sales in the Films and Plastics segment totaled ¥93.0 billion. Operating income was ¥5.7 billion.

Plastics

Demand for polycarbonate resin softened, while prices for raw materials remained high.

Demand for mainstay polycarbonate resin for automotive applications and for use in electrical and electronics

equipment, which had fallen off in the wake of the earthquake, began to recover in the summer. However, the

plastics business as a whole struggled as overall demand deteriorated further, owing to the recessionary shadow

cast by the downgrade of the U.S. sovereign credit rating and the European financial crisis, and raw materials

prices remained high. Among new products, a series of light-diffusion grade polycarbonate resin products

developed for LED lighting applications garnered a significant share of this expanding market, bolstered by the

rising preference for products that help reduce energy consumption and increase energy efficiency. In the area of

processed polycarbonate resin products, sales of polycarbonate sheet for automotive and entertainment-related

applications and of PURE-ACE® polycarbonate retardation film for use in 3D glasses for movie theaters

deteriorated, the former due to a drop in orders after the earthquake and the latter to flagging interest in 3D movies

and a move toward inventory adjustments. In July, demand for processed polycarbonate sheet products began to

revive, particularly for dummy cans for use in vending machines and for automotive instrument panels. Demand for

reverse-dispersion solvent-cast retardation film also picked up, owing to its adoption for use as antireflective film

for new mobile phone models and other factors. Looking ahead, we will strive to expand sales of transparent

electroconductive film developed for capacitive touch screens and of SCINTIREX™, a new radiation-fluorescent

plastic.

Films

Demand for PET film was firm in Asia, but showed signs of softening in the United States and Europe.

We currently have polyester films joint ventures with E.I. du Pont de Nemours and Company (DuPont) of the

United States in six countries. In Japan, demand for PET film remained brisk for use as flat panel display (FPD)

reflective film and in solar cell back sheets, the principal applications for this product, despite showing signs of

softening toward the end of the second quarter. In the wake of the Great East Japan Earthquake, we temporarily

suspended production at our Utsunomiya Factory, in Tochigi Prefecture, and our Ibaraki Factory, in Ibaraki

Prefecture, which hampered our supply capabilities. However, both facilities have resumed production on all lines,

the Ibaraki Factory in late March and the Utsunomiya Factory in mid-June 2011.

Despite persistently strong demand in the PRC, a rush by local manufacturers to expand production capacity upset

the supply–demand balance, a situation that negatively affected our local joint venture’s sales prices. In the United

States, we completed crucial structural reforms at the end of February 2011 with the conclusion of the phased

closure of our plant in Florence, South Carolina. However, with demand for use in solar cell back sheets—brisk

until fiscal 2010—weak in both the United States and Europe from the second quarter, we were forced to

temporarily suspend production of certain product lines to make necessary inventory adjustments.

- 3 -

Pharmaceuticals and Home Health Care

Sales in the Pharmaceuticals and Home Health Care segment amounted to ¥68.0 billion, while operating income

was ¥11.9 billion.

Pharmaceuticals

We began marketing a promising new drug, FEBURIC®, in Japan.

In Japan, sales continued to expand favorably for Synvisc Dispo™, an intra-articular injection-form drug for treating

pain associated with osteoarthritis of the knee launched in December 2010, and FEBURIC®, a novel treatment for

hyperuricemia and gout developed in-house, which was launched in May 2011. We also saw steady sales of

osteoporosis treatment Bonalon®.*

Overseas, sales of our innovative hyperuricemia treatment were favorable in North America, where it is sold under

the name ULORIC®, and in Europe, where it is known as ADENURIC®. In July 2011, we commenced sales of the

drug in the Republic of Korea (ROK) under the name FEBURIC®. We also signed exclusive distributorship

agreements in April 2011 with licensees Takeda Pharmaceuticals North America, Inc., for marketing in Mexico and

the Caribbean, and Algorithm SAL of Lebanon, for marketing in the Middle East and North Africa, and in August

2011 with Astellas Pharma Inc. for marketing in Southeast Asia and India.

In R&D, in July 2011 we commenced clinical testing of GGS-MPA (human immunoglobulin preparation Venilon®)

for the treatment of microscopic polyangiitis, a new indication. In August and September, we filed for approval to

manufacture and market, respectively, GTH-42J, a new oral jelly form of osteoporosis treatment Bonalon®, and

ITM-014, a cutting-edge treatment for acromegaly licensed in from Ipsen Pharma SAS of France. Also in

September, we commenced phase I clinical trials for NA872ET, a small, sustained-release tablet-form version of

expectorant Mucosolvan®.

Home Health Care

Rental volume remained favorable.

In Japan, rental volume for mainstay home oxygen therapy (HOT) equipment remained firm. Rentals of continuous

positive airway pressure (CPAP) ventilators, used to treat sleep apnea syndrome, also increased, as we sought to

capitalize on new product SLEEPMATE® S9, a silent, easy-to-use positive pressure ventilator launched in April

2011, to strengthen our share of the domestic market. Rentals of other equipment, including noninvasive positive

pressure ventilators (the NIP NASAL® series and AutoSet™ CS) and SAFHS® (Sonic Accelerated Fracture Healing

System) were healthy.

Overseas, we currently provide home health care services in the United States, Spain and the ROK. In all three

markets, we took steps to ensure the steady expansion of rental volume and sought to reinforce our earnings base

by improving the efficiency of operations.

* Bonalon® is the registered trademark of Merck Sharp & Dohme Corp., Whitehouse Station, NJ, U.S.A.

- 4 -

Trading and Retail

The Trading and Retail segment yielded sales of ¥105.4 billion, while operating income was ¥2.4 billion. Results for

textiles and apparel were firm, thanks to increased efficiency in both production and sales, as were results for

industrial textiles and materials, owing to an improvement in overall market conditions.

Textiles and Apparel

Sales of sportswear, everyday apparel and men’s suits rose, reflecting efforts in our mainstay OEM apparel

business to bolster our market share, notably by enhancing marketing collaboration with blue-chip customers, and

to expand production in the Association of Southeast Asian Nations (ASEAN) region. The operating margin

improved, augmented by steps taken to reduce costs through greater production efficiency and the integration of

production facilities.

Industrial Textiles and Materials

Although sales of products for automotive-related applications flagged early in the first half, owing to the Great

East Japan Earthquake, demand rallied toward the end of the period. In the area of general-purpose products,

market conditions recovered across the board, pushing up sales of mainstay industrial fabrics, nonwoven materials,

filters and materials for civil engineering and fisheries-related applications. In film- and resin-related products, film

and sheet sales for use in LCDs sagged, while sales of heat-insulating films rose, bolstered by demand related to

efforts to reduce energy consumption.

Qualitative Information on Financial Position and Cash Flows

Analysis of Assets, Liabilities, Net Assets and Cash Flows

Assets, Liabilities and Net Assets

Total assets as of September 30, 2011, amounted to ¥784.5 billion, an increase of ¥23.0 billion from the end of

fiscal 2010. This result was primarily a consequence of higher inventories, attributable to a backlog—caused by

regularly scheduled maintenance—and seasonal factors, as well as to contracting demand.

Total liabilities, at ¥474.2 billion, were up ¥20.3 billion from the fiscal 2010 year-end. Interest-bearing debt, which

includes commercial paper, short-term loans payable and long-term loans payable, rose ¥20.6 billion, to ¥288.0

billion, mainly attributable to the procurement of funds to increase working capital.

Total net assets were ¥310.3 billion, an increase of ¥2.6 billion. Shareholders’ equity and total valuation and

translation adjustments together represented ¥290.1 billion of the total, up ¥5.8 billion. This increase was due to,

among others, quarterly net income of ¥9.2 billion and occurred despite a decrease in the value of investment

securities, the result of a sharp decline in share prices, which pushed down the valuation difference on

available-for-sale securities.

- 5 -

Cash Flows

As a consequence of operating activities, which provided ¥1.6 billion, plus investing activities, which used ¥18.3

billion, plus financing activities, which provided ¥14.4 billion, cash and cash equivalents as of September 30, 2011,

amounted to ¥26.3 billion, down ¥2.1 billion from the end of fiscal 2010.

Net cash and cash equivalents provided by operating activities in the first half of fiscal 2011, at ¥1.6 billion, was

¥19.5 billion less than in the first half of fiscal 2010. Factors contributing to this result included income before

income taxes of ¥19.7 billion and depreciation and amortization of ¥23.2 billion, which countered the impact of an

increase in working capital of ¥32.1 billion and combined interest paid and income taxes paid of ¥5.3 billion.

Net cash and cash equivalents used in investing activities amounted to ¥18.3 billion, ¥5.5 billion greater than in the

corresponding period of the previous fiscal year. This was attributable primarily to outlays for purchase of property,

plant and equipment.

Net cash and cash equivalents provided by financing activities amounted to ¥14.4 billion, compared with ¥5.3

billion used in such activities in the fiscal 2010 first half. This result was despite outlays for cash dividends paid and

the redemption of debentures, and reflected an increase in short-term bank loans, net.

Qualitative Information on Outlook for Operating Results

Outlook for Fiscal 2011

Forecast for Operating Results

(Billions of yen/%)

Net sales Operating income Ordinary income Net income

Fisca1 2011 (forecast) ¥890.0 ¥50.0 ¥50.0 ¥24.0

Fiscal 2010 815.7 48.6 50.3 25.2

Change 74.3 1.4 –0.3 –1.2

Percentage change 9.1% 3.0% –0.7% –4.7%

With the successful conclusion of key structural reforms, we made a decisive return to profitability at the net

income level in fiscal 2010 after two consecutive full-term net losses. Having designated fiscal 2011 as the year for

repositioning Teijin on a growth trajectory, our focus for the current period was on further enhancing profitability.

However, owing to a global economic slowdown triggered by the European sovereign debt and financial crises,

results in several segments—notably Films and Plastics—are expected to continue struggling in the third and

fourth quarters. In addition, in October 2011 the severe flooding in Thailand resulted in damage to production

facilities belonging to certain local subsidiaries, all of which were forced to suspend operations.

For fiscal 2011, we currently forecast consolidated net sales of ¥890.0 billion, operating income of ¥50.0 billion,

- 6 -

ordinary income of ¥50.0 billion and net income of ¥24.0 billion, all of which are down from our previous forecasts,

published August 1, 2011. These forecasts take into account an estimate of the impact of flooding in Thailand on

our business, based on information currently available to us. However, because it is difficult at this time to calculate

losses resulting from damage to production facilities and inventory, these forecasts do not reflect the impact of

those factors. Once the full extent of damage and the resulting disruption to our supply chain has become clearer,

should it seem likely results will diverge from these figures, we will promptly release revised forecasts.

With the aim of guaranteeing timely disclosure and the efficiency of business performance management, effective

from fiscal 2011 all consolidated subsidiaries will close their books on March 31. As a consequence, for this fiscal

year only, certain consolidated subsidiaries will report operating results for a 15-month period (January 1,

2011–March 31, 2012).

Our current consolidated results forecasts assume exchange rates of ¥79 to US$1.00 and ¥111 to €1.00 and a

Dubai crude oil price of US$109 per barrel.

Outlook for Segment Results

(Billions of yen)

Net sales Operating income

First halfFull term

(Forecast)First half

Full term(Forecast)

High-Performance Fibers ¥ 54.4 ¥130.0 ¥ 4.2 ¥11.5

Polyester Fibers 53.9 120.0 2.0 3.5

Films and Plastics 93.0 225.0 5.7 12.5

Pharmaceuticals and Home Health Care 68.0 150.0 11.9 28.0

Trading and Retail 105.4 225.0 2.4 5.0

Total 374.7 850.0 26.2 60.5

Others 18.9 40.0 1.1 3.0

Elimination and corporate — — (6.7) (13.5)

Consolidated total ¥393.6 ¥890.0 ¥20.7 ¥50.0

- 7 -

2. Other Information

Changes in significant subsidiaries during the period under review:None

Adoption of special quarterly accounting methods:Calculation of tax expense

Certain of the Company’s consolidated subsidiaries have adopted a method for estimating in practical terms the

effective tax rate for the fiscal year, including for the first and second quarters, following the application of tax effect

accounting to income before income taxes, and multiplying this by quarterly income before income taxes to

estimate quarterly tax expense.

Changes in accounting principles, procedures and presentation methods:Change in the method for determining depreciation of tangible fixed assets

To date, the Company and its domestic consolidated subsidiaries have determined depreciation of tangible fixed

assets principally using the declining-balance method, while overseas consolidated subsidiaries have used the

straight-line method. However, effective from the first quarter of fiscal 2011, the Company and all its consolidated

subsidiaries adopted the straight-line method.

Since fiscal 2009, the Company has been implementing structural reforms aimed at, among others, establishing

optimal global production configurations. These efforts have enabled the Company to achieve stable operating

rates for its various production facilities. Having designated fiscal 2011 as the year for repositioning the Teijin

Group on a growth trajectory, the Company has lifted the moratorium it has placed on major capital investment to

promote promising new businesses.

The Company recognizes the essential completion of structural reforms and its new policy regarding capital

investment as an important opportunity. The decision to adopt the straight-line method for the Company and all its

consolidated subsidiaries, in Japan and overseas, came as a result of this recognition, as well the outcome of an

examination of the need to employ a method that both facilitates a fair and impartial assessment of Group

companies’ operating results and appropriately reflects Group facilities’ potential for stable operation at present

and in the future. The impact of this change on consolidated results for the first two quarters has increased

consolidated operating income by ¥2,559 million, ordinary income by ¥2,622 million and income before income

taxes by ¥2,675 million. The impact of this change on segment results is outlined in the section titled “Segment

Information, etc.”

Additional Information:Application of Accounting Standard for Accounting Changes and Error Corrections

Effective from the first quarter of fiscal 2011, the Company applied the Accounting Standard for Accounting

Changes and Error Corrections (Accounting Standards Board of Japan (ASBJ) Statement No. 24, issued on

December 4, 2009) and the Guidance on Accounting Standard for Accounting Changes and Error Corrections

(ASBJ Guidance No. 24, issued on December 4, 2009) to accounting changes implemented and corrections to

past errors made from the beginning of the first quarter onward.

- 8 -

Change in provision of retirement benefits for directors and corporate auditors

At the ordinary general meeting of shareholders held on June 22, 2011, shareholders approved a proposal to

abolish the retirement benefits payment system for retiring directors and corporate auditors and to pay accrued

retirement benefits associated with the abolishment of the system, with the timing of payment to be upon

retirement. As a consequence, an amount equivalent to accrued retirement benefits due to directors and corporate

auditors up to the close of the aforementioned ordinary general meeting of shareholders (¥1,102 million) is

included in other noncurrent liabilities.

Italicized product names and service names in this report denoted with ™ or ® are trademarks or registered trademarks of the

Teijin Group in Japan and/or other countries. Other product names and service names used in this document may be protected

as the trademarks and/or trade names of other companies.

- 9 -

3. Financial Statements

(1) Consolidated Balance Sheets

(Million yen)

As of March 31, 2011 As of September 30, 2011

< Assets >

Current assets

Cash and time deposits 28,612 26,502

Trade notes and accounts receivable 156,132 160,394

Finished goods 71,448 97,681

Work in process 9,163 11,351

Raw materials and supplies 24,895 31,538

Other current assets 48,756 44,225

Allowance for doubtful receivables (2,113) (2,268)

Total 336,894 369,424

Noncurrent assets

Property, plant and equipment

Buildings and structures, net 72,046 71,347

Machinery and equipment, net 121,340 114,343

Other, net 66,272 70,849

Total 259,659 256,540

Intangible assets

Goodwill 51,773 50,678

Other 15,842 15,840

Total 67,615 66,519

Investments and other assets

Investment securities 57,020 53,176

Other 42,314 41,137

Allowance for doubtful receivables (1,969) (2,277)

Total 97,365 92,036

Total noncurrent assets 424,640 415,096

761,534 784,520Total assets

- 10 -

(Million yen)

As of March 31, 2011 As of September 30, 2011

< Liabilities >

Current liabilities

Trade notes and accounts payable 87,283 93,500

Short-term loans payable 44,568 60,661

Current portion of long-term loans payable 12,983 56,208

Commercial paper 33,000 27,000

Current portion of bonds 5,958 2,010

Income taxes payable 7,459 3,679

Other current liabilities 53,516 50,517

Total 244,770 293,578

Noncurrent liabilities

Bonds payable 30,000 30,000

Long-term loans payable 138,870 110,042

Provision for retirement benefits 18,153 18,375

Other 22,041 22,177Total 209,065 180,595

453,836 474,173

<Net assets>

Shareholders' equity

Capital stock 70,816 70,816

Capital surplus 101,373 101,378

Retained earnings 135,385 141,617

Treasury stock (151) (140)

Total 307,423 313,672

Valuation and translation adjustments

Valuation difference on available-for-sale securities 10,823 7,929

Deferred gains (losses) on hedges (198) 662

Foreign currency translation adjustment (33,812) (32,189)

Total (23,186) (23,597)

Subscription rights to shares 439 414

Minority interests 23,023 19,858

Total net assets 307,698 310,347

Total liabilities and net assets 761,534 784,520

Total liabilities

- 11 -

(2) Consolidated Statements of Income

(Million yen)

For the second quarter ended

September 30, 2010

For the second quarter ended

September 30, 2011

Net sales 399,869 393,567

Cost of sales 290,025 281,743

Gross profit 109,844 111,823

Selling, general and administrative expenses 89,332 91,170

Operating income 20,511 20,652

Non-operating income

Interest income 242 274

Dividend income 516 450

Equity in earnings of affiliates 2,597 3,871

Other income 358 499

3,715 5,096

Non-operating expenses

Interest expenses 2,279 2,093

Foreign exchange losses 275 759

Other expenses 1,178 1,232

3,734 4,086

Ordinary income 20,492 21,663

Extraordinary income

Gain on sales of investment securities 1,184 ―

Gain on sales of subsidiaries and affiliates' stocks ― 705

Other 322 249

1,506 954

Extraordinary loss

Loss on sales and retirement of non-current assets 194 191

Write-down of investment securities 189 653

Loss on impairment 84 980

Restructuring costs 954 ―

Provision for allowance for doubtful accounts ― 392

Earthquake-related expenses ― 426

Loss on adjustment for changes of accounting standard for asset

retirement obligations529 ―

Other 860 260

2,812 2,904

Income before income taxes 19,186 19,712

Income taxes 6,881 9,356

Income before minority interests 12,305 10,356

Minority interests in income 758 1,171

Net income 11,546 9,184

Total

Total

Total

Total

- 12 -

(Consolidated Statements of Comprehensive Income)

(Million yen)

Income before minority interests 12,305 10,356

Other comprehensive income

Valuation difference on available-for-sale securities (3,887) (2,881)

Deferred gains (losses) on hedges (3,069) 862

Foreign currency translation adjustment (3,937) 1,970

814 (404)

(10,079) (452)

Comprehensive income 2,225 9,903

Breakdown of comprehensive income:

Comprehensive income attributable to owners of the parent 1,507 8,774

Comprehensive income attributable to minority interests 718 1,129

Total

Share of other omprehensive income of associates accounted for using

the equity method

For the second quarter ended

September 30, 2010

For the second quarter ended

September 30, 2011

- 13 -

(3) Consolidated Statements of Cash Flows

(Million yen)

Cash flows from operating activities

Income before income taxes 19,186 19,712

Depreciation and amortization of others 28,009 23,195

Interest and dividend income (759) (725)

Interest expense 2,279 2,093

Equity in losses (earnings) of affiliates (2,597) (3,871)

Decrease (increase) in receivables (5,736) (3,651)

Decrease (increase) in inventories (10,620) (34,413)

Increase (decrease) in payables 4,872 6,002

Other, net (11,333) (2,373)

Subtotal 23,300 5,968

Interest and dividends received 1,205 1,000

Interest paid (2,350) (2,222)

Income taxes paid (1,018) (3,099)

Net cash and cash equivalents provided by operating activities 21,136 1,647

Cash flows from investing activities

Purchase of property, plant and equipment (11,590) (13,122)

Purchase of investment securities (3,631) (36)

Purchase of investments in subsidiaries ― (4,950)

Other, net 2,396 (174)

Net cash and cash equivalents used in investing activities (12,824) (18,283)

Cash flows from financing activities

Increase (decrease) in short-term bank loans, net (3,528) 16,950

Increase (decrease) in commercial paper 14,000 (6,000)

Proceeds from long-term debt 3,626 20,000

Repayment of long-term debt (9,751) (8,128)

Issue of debentures 13,572 2,013

Redemption of debentures (18,697) (5,610)

Cash dividends paid (1,964) (2,952)

Cash dividends paid to minority shareholders (2,472) (1,676)

Other, net (46) (146)

Net cash and cash equivalents provided by financing activities (5,261) 14,449

Effect of exchange rate changes on cash and cash equivalents (480) 76

Net increase in cash and cash equivalents 2,569 (2,109)

Cash and cash equivalents at beginning of period 22,964 28,454

112 ―

Cash and cash equivalents at end of period 25,646 26,344

Increase of cash and cash equivalents due to change in scope

of consolidation

For the second quarter ended

September 30, 2010

For the second quarter ended

September 30, 2011

- 14 -

(4) Notes Pertaining to Going Concern AssumptionNo

(5) Segment Information, etc.Ｉ. Outline of segments

The Company's reportable operating segments are components of an entity for which separate financial information is availableand evaluated regularly by the chief decision-making authority in determining the allocation of management resources and inassessing performance. The Company currently divides its operations into business groups, based on type of product/natureof business/services provided. The business groups formulate product and service strategies in a comprehensive manner inJapan and overseas.

Accordingly, the Company divides its operations into five reportable operating segments on the same basis as it uses internally:High-Performance Fibers (Aramid Fibers and Carbon Fibers and Composites); Polyester Fibers; Films and Plastics (Plasticsand Films); Pharmaceuticals and Home Health Care; and Trading and Retail.

Within the High-Performance Fibers segment, Aramid Fibers encompasses production and sale of thread, staple fibers andtextiles, and of synthetic leather, while Carbon Fibers and Composites encompasses the production and sale of carbon fibersproducts. Polyester Fibers includes the production and sale of filament yarn, staple fibers, spun yarn, processed fibers, nonwoven

fabrics and textiles, as well as of polyester raw materials. Within the Films and Plastics segment, Plastics involves the productionand sale of polycarbonate resin, other resins and resin products, while Films includes the production and sales of polyester films.Pharmaceuticals and Home Health Care encompasses the production and sales of pharmaceuticals, the production and rentalof home health care equipment and the provision of home health care services. Trading & Retail focuses on the planning and

sales of textile products.

ＩＩ. FY10 2Q results (Apr. 2010 - Sep. 2010)Notes: 1. Corporate expenses are expenses that cannot be allocated to individual reportable operating segments and are primarily

related to basic research and head office administration. (Million yen)

High-

Performance

Fibers

Polyester

Fibers

Films &

Plastics

Pharma. &

H. H. Care

Trading &

RetailTotal

1) External customers 52,113 50,864 110,815 66,480 102,193 382,468 17,400 399,8692) Intersegment transactions or

transfers 5,344 20,240 3,850 0 2,301 31,736 15,003 46,739Net sales 57,458 71,105 114,666 66,480 104,494 414,204 32,404 446,608Segment income (loss) 1,158 (10) 10,937 11,809 1,919 25,813 897 26,711Note: "Others," which includes the Company's IT business, does not qualify as a reportable operating segment.

2. Difference between operating income and sum of operating income (loss) in reportable operating segments

(Adjustment) (Million yen)

Total reportable operating segmentsOthers segmentElimination of intersegment transactionsCorporate expenses*Operating incomeNote: Corporate expenses are expenses that cannot be allocated to individual reportable operating segments and are

primarily related to basic research and head office administration.

3. Loss on impairment and goodwill by reportable segmentsNo

20,511

140(6,340)

25,813897

Operating income

Sales

Grand

total

Reportable operating segments

Others*

Amount

- 15 -

ＩＩＩ. FY11 2Q results (Apr. 2011 - Sep. 2011)1. Segment sales and operating income (loss)

(Million yen)

High-

Performance

Fibers

Polyester

Fibers

Films &

Plastics

Pharma. &

H. H. Care

Trading &

RetailTotal

1) External customers 54,381 53,923 92,951 68,043 105,364 374,665 18,901 393,5672) Intersegment net

sales or transfer 5,177 17,155 3,081 0 2,039 27,453 16,933 44,386Net sales 59,559 71,079 96,033 68,043 107,404 402,119 35,834 437,954Segment income 4,230 1,994 5,724 11,914 2,358 26,223 1,086 27,310Note: "Others," which includes the Company's IT business, does not qualify as a reportable operating segment.

2. Difference between operating income and sum of operating income (loss) in reportable operating segments

(Adjustment) (Million yen)

Total reportable operating segmentsOthers segmentElimination of intersegment transactionsCorporate expenses*Operating incomeNotes: 1. Corporate expenses are expenses that cannot be allocated to individual reportable operating segments and are primarily

related to basic research and head office administration.2. As explained in Changes in accounting principles, procedures and presentation methods, in the section titled 2. Other

Information, the Company and its domestic consolidated subsidiaries, which have to date determined depreciation—principally of equipment— using the declining balance method, have, effective from the first quarter of FY11,adopted the straight-line method. The impact of this change in the first quarter of FY11 was to increase operating incomeby \120 million in the High-Performance Fibers segment, \113million in the Polyester Fibers segment, \230 million in theFilms and Plastics segment, \497 million in the Pharmaceuticals and Home Health Caresegment and \55 million in the Otherssegment, and to reduce corporate expenses by \169 million, compared to what would have been the case had the formermethod had been used.

3. Loss on impairment and goodwill by reportable segmentsNo

(6) Notes on Significant Changes in Shareholders' EquityNo

(7) Subsequent EventFlooding in Thailand

Owing to the severe flooding in Thailand this year, in October 2011 production facilities belonging to certain Teijin Group subsidiaries inthe country have been inundated or otherwise damaged. As entry into these facilities is not currently possible, we are unable at thistime to accurately calculate the financial impact of this event, net of the amount of insurance settlements, nor to estimate when thesefacilities will be able to resume normal operations.

57(6,715)20,652

Grand

total

26,2231,086

Sales

Reportable operating segments

Others*

Operating income Amount

- 16 -

1. Movement of consolidated results

(1) Movement of results(Billion yen)

FY2010 1Q FY2010 2Q FY2010 3Q FY2010 4Q FY2011 1Q FY2011 2Q

Net sales 192.6 207.3 206.3 209.5 189.6 204.0

Operating income 8.1 12.4 15.9 12.2 11.0 9.6

Ordinary income 7.8 12.7 16.9 12.9 12.8 8.9

Net income 4.0 7.5 8.5 5.2 6.3 2.9

(2) Movement of industrial segment information(Billion yen)

FY2010 1Q FY2010 2Q FY2010 3Q FY2010 4Q FY2011 1Q FY2011 2Q

Net sales

High-Performance Fibers 25.6 26.5 24.7 26.6 26.9 27.5

Polyester Fibers 24.7 26.2 24.9 27.7 23.8 30.2

Films & Plastics 51.8 59.1 54.8 51.5 46.9 46.1

Pharma. & H. H. Care 33.7 32.8 35.7 34.2 34.9 33.1

Trading & Retail 48.7 53.5 58.1 56.7 48.2 57.2

Total 184.5 198.0 198.2 196.6 180.6 194.1

Others 8.1 9.3 8.0 12.9 9.0 9.9

Consolidated total 192.6 207.3 206.3 209.5 189.6 204.0

Operating income

High-Performance Fibers 0.0 1.1 1.2 2.1 2.0 2.2

Polyester Fibers 0.0 (0.0) 1.4 1.6 0.5 1.5

Films & Plastics 3.6 7.3 8.1 4.4 3.2 2.6

Pharma. & H. H. Care 6.9 4.9 6.8 4.3 7.2 4.7

Trading & Retail 0.7 1.2 1.6 1.2 1.0 1.3

Total 11.3 14.6 19.2 13.6 13.9 12.3

Others (0.1) 1.0 0.2 2.0 0.3 0.8

Elimination & corporate (3.1) (3.1) (3.5) (3.4) (3.2) (3.5)

Consolidated total 8.1 12.4 15.9 12.2 11.0 9.6

2. Capital expenditure, depreciation & amortization expenses and research & development expenses (consolidated)(Billion yen)

FY2008 FY2009 FY2010 FY2011 2Q FY2011

(Actual) (Actual) (Actual) (Actual) (Outlook)

69.6 30.8 25.3 11.4 40.0

75.8 36.3 29.2 12.9 45.0

67.4 61.9 56.4 23.2 55.0

37.6 33.4 31.5 15.2 33.0

*Depreciation and amortization includes amortization of goodwill.

3. Number of employees (Consolidated)

End of FY08 End of FY09 End of FY10End of

FY11 2Q

19,453 18,778 17,542 17,680

Research & development

Supplementary Information

Depreciation & amortization*

Consolidated

Capital expenditure:

CAPEX for tangible assets

Total

- 17 -

4. Foreign Exchange Rate(1) BS exchange rate for overseas subsidiaries (End of fiscal year)

92 81 81 77

1.43 1.32 1.45 1.41

(2) PL exchange rate for overseas subsidiaries (Average of fiscal year)

94 88 82 79

1.39 1.33 1.40 1.41

5. Sales of principal pharmaceuticals(Billion yen)

Bonalon® Osteoporosis

Onealfa® Osteoporosis

Mucosolvan® Expectorant

Venilon® Severe infectious diseases

Laxoberon® Laxative

Tricor® Hyperlipidemia

Bonalfa® Psoriasis

Alvesco® Asthma

Spiropent® Bronchodilator

Synvisc Dispo™

Feburic® Hyperuricemia and gout

6. Development status of new pharmaceuticals

(As of September 30, 2011)

ProductsTMX-67BTR-15K

TV-02H

GTH-42V Filed in Japan in February 2011GTH-42J Filed in Japan in August 2011ITM-014 Filed in Japan in September 2011

GGS(Venilon®)ITM-077NTC-801

GGS(Venilon®)ITM-058NA872ET

FY2009 FY2010 FY2011 2Q FY2011

(Actual)

FY2009 FY2010 FY2011 2Q

(Actual)

JPY/US$

US$/EURO

(Actual) (Actual)

Ph Ⅰ

Commenced sales in Japan in May, 2011Stage

(Actual) (Outlook)

FY2011

(Actual) (Outlook)

Ph Ⅲ

Commenced sales in Japan in April, 2011

21.0 10.3

11.9 11.4 5.4

21.3

10.3 10.0 4.5

8.0 9.1 4.5

4.7 4.4 2.1

1.6 1.8 0.7

1.6 0.7

1.1 1.2 0.6

1.0 0.5

― 0.7 0.9

Ph ⅡTypeII Diabetes

Ph Ⅰ

Ph ⅡAtrial fibrillation and flutter

OsteoporosisMicroscopic PolyAngitis (MPA) Ph Ⅱ

Expectorant

― 0.5

Additional filing for low-concentration preparation in

September 2010(PRC)

―

Asthma in childrenGout and hyperuricemia

FY2010 FY2011 2Q

(Actual) (Actual) (Actual)

Multiple Sclerosis (MS)

Acromegaly

Target disease

Osteoporosis

Osteoarthritis pain in the knee

Osteoporosis

Psoriasis

JPY/US$

US$/EURO

Products IndicationFY2009

1.1

1.7

- 18 -